Trials / Completed
CompletedNCT02345044
A Study to Evaluate Efficacy and Safety of CS-3150 in Japanese Hypertensive Subjects
A Randomized, Double-blind, Placebo-controlled, Multi-center Study to Evaluate Efficacy and Safety of CS-3150 in Japanese Subjects With Hypertension
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 426 (actual)
- Sponsor
- Daiichi Sankyo · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
This study is a randomized, placebo-controlled, double-blind, multi-center study to evaluate efficacy and safety of different doses of CS-3150 compared to placebo in Japanese hypertensive subjects. Primary endpoint is change from baseline in sitting systolic and diastolic blood pressure.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | CS-3150 | |
| DRUG | placebo | |
| DRUG | eplerenone |
Timeline
- Start date
- 2015-01-01
- Primary completion
- 2015-08-01
- Completion
- 2015-10-01
- First posted
- 2015-01-26
- Last updated
- 2019-10-08
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT02345044. Inclusion in this directory is not an endorsement.